The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses

F Leichsenring, C Steinert, S Rabung… - World …, 2022 - Wiley Online Library
Mental disorders represent a worldwide public health concern. Psychotherapies and
pharmacotherapies are recommended as first line treatments. However, evidence has …

[HTML][HTML] The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder

SV Faraone, T Banaschewski, D Coghill… - Neuroscience & …, 2021 - Elsevier
Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

[HTML][HTML] Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit …

S Young, N Adamo, BB Ásgeirsdóttir, P Branney… - BMC psychiatry, 2020 - Springer
Background There is evidence to suggest that the broad discrepancy in the ratio of males to
females with diagnosed ADHD is due, at least in part, to lack of recognition and/or referral …

Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review

L Kazda, K Bell, R Thomas, K McGeechan… - JAMA network …, 2021 - jamanetwork.com
Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

[HTML][HTML] Evidence-based pharmacological treatment options for ADHD in children and adolescents

K Mechler, T Banaschewski, S Hohmann… - Pharmacology & …, 2022 - Elsevier
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …

Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and …

L Wang, QQ Wang, PB Davis, ND Volkow… - World …, 2022 - Wiley Online Library
Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19
infection and for adverse outcomes of the infection. Though vaccines are highly effective …

[HTML][HTML] An update on psychopharmacological treatment of autism spectrum disorder

R Aishworiya, T Valica, R Hagerman, B Restrepo - Neurotherapeutics, 2023 - Elsevier
While behavioral interventions remain the mainstay of treatment of autism spectrum disorder
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

JJS Kooij, D Bijlenga, L Salerno, R Jaeschke… - European …, 2019 - cambridge.org
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …

Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric …

M Solmi, M Fornaro, EG Ostinelli, C Zangani… - World …, 2020 - Wiley Online Library
Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

[HTML][HTML] A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial

SH Kollins, DJ DeLoss, E Cañadas, J Lutz… - The Lancet Digital …, 2020 - thelancet.com
Background Attention-deficit hyperactivity disorder (ADHD) is a common paediatric
neurodevelopmental disorder with substantial effect on families and society. Alternatives to …